AlzChem Group AG
XETRA:ACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iochpe Maxion SA
BOVESPA:MYPK3
|
BR |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.9), the stock would be worth €50.14 (71% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.1 | €173.7 |
0%
|
| 3-Year Average | 0.9 | €50.14 |
-71%
|
| 5-Year Average | 0.6 | €33.23 |
-81%
|
| Industry Average | 0.9 | €50.84 |
-71%
|
| Country Average | 1.3 | €75.91 |
-56%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
€1.5B
|
/ |
Jan 2026
€562.1m
|
= |
|
|
€1.5B
|
/ |
Dec 2026
€607.3m
|
= |
|
|
€1.5B
|
/ |
Dec 2027
€709.5m
|
= |
|
|
€1.5B
|
/ |
Dec 2028
€805.1m
|
= |
|
|
€1.5B
|
/ |
Dec 2029
€888.2m
|
= |
|
|
€1.5B
|
/ |
Dec 2030
€962.8m
|
= |
|
|
€1.5B
|
/ |
Dec 2031
€1B
|
= |
|
|
€1.5B
|
/ |
Dec 2032
€1.1B
|
= |
|
|
€1.5B
|
/ |
Dec 2033
€1.1B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| DE |
|
AlzChem Group AG
XETRA:ACT
|
1.8B EUR | 3.1 | 27.7 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83.3B USD | 4 | 32.4 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13T JPY | 4.6 | 26.8 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.5B USD | 5.1 | 36.4 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.8 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
278.5B CNY | 1.6 | 21.2 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 4 | 24.4 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.4 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 6.7 | 61.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.6B USD | 1.8 | 15.6 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.9 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.3 |
| 70th Percentile | 2.5 |
| Max | 21 171.2 |
Other Multiples
AlzChem Group AG
Glance View
AlzChem Group AG engages in the development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,636 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
